Cancer BiologybioRxivPreprint
S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypes
Reuben J. Hoffmann, AeSoon L. Bensen, Mark A. Dane…·Pepper S. Schedin
This study identifies SNO-COX-2 as a biomarker for mesenchymal phenotypes in breast cancer, showing its microenvironmental regulation and association with invasive growth.